Bart L. Scott

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

Bart L. Scott, Marcelo C. Pasquini, Brent R. Logan et al. · Journal of Clinical Oncology · 2017 · 649 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Optimal Regimen Intensity +16

Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease

Christopher S. Hourigan, Laura W. Dillon, Gege Gui et al. · Journal of Clinical Oncology · 2019 · 428 citations · Full text

Comorbidity and Disease Status–Based Risk Stratification of Outcomes Among Patients With Acute Myeloid Leukemia or Myelodysplasia Receiving Allogeneic Hematopoietic Cell Transplantation

Mohamed L. Sorror, Brenda M. Sandmaier, Barry E. Storer et al. · Journal of Clinical Oncology · 2007 · 395 citations · Full text

Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis

Bart L. Scott, Brenda M. Sandmaier, Barry E. Storer et al. · Leukemia · 2005 · 233 citations

Hematological Malignancy, Multilineage Dysplasia, Transplantation +9

Hematopoietic Stem-Cell Transplantation for Advanced Systemic Mastocytosis

Celalettin Üstün, Andreas Reiter, Bart L. Scott et al. · Journal of Clinical Oncology · 2014 · 181 citations · Full text